Raynaud’s phenomenon is seen in:
**Core Concept**
Raynaud's phenomenon is a vasospastic disorder characterized by episodic vasospasm of the digital arteries, leading to a reduction in blood flow to the fingers and toes. This results in a classic triad of pallor, cyanosis, and rubor, which are manifestations of the pathophysiological process.
**Why the Correct Answer is Right**
The correct answer involves the pathophysiology of Raynaud's phenomenon, which is primarily mediated by the release of vasoconstrictor substances such as serotonin, thromboxane A2, and endothelin-1 from platelets and the endothelium. The resultant vasospasm is exacerbated by impaired vasodilatory mechanisms, including the reduced release of nitric oxide and prostacyclin. The trigger for this process can be a combination of factors, including cold temperatures, emotional stress, and certain medications.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because while systemic lupus erythematosus (SLE) can cause vasculitis, it is not typically associated with the classic triad of pallor, cyanosis, and rubor characteristic of Raynaud's phenomenon.
* **Option B:** This option is incorrect because while certain medications can trigger Raynaud's phenomenon, it is not a primary pathophysiological mechanism of the disorder.
* **Option C:** This option is incorrect because while atherosclerosis can cause peripheral artery disease, it is not typically associated with the episodic vasospasm characteristic of Raynaud's phenomenon.
**Clinical Pearl / High-Yield Fact**
Raynaud's phenomenon is often associated with autoimmune disorders, such as scleroderma, and can be a significant indicator of underlying disease. A thorough medical history and physical examination are essential in diagnosing and managing this condition.
**Correct Answer: C. Scleroderma**